EUVIMEDEUVIMED entdecken
Crossref

Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure

Helen L Zhang, Hayley Nemeth, E Wilbur Woodhouse iD, Clemontina A Davenport, Cliburn Chan, Nwora Lance Okeke, Susanna Naggie

Journal of Viral Hepatitis · 2024

DOI: 10.1111/jvh.14009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2024. Verfasst von Helen L Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Sustained Virologic Response, Hepatitis C, Chronic, Antiviral Agents, Alanine Transaminase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: NIH-NCATS UL1TR002553, NIH-NIAID T32-AI055435, NIH-NIAID R25AI140495.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A subset of patients with chronic hepatitis C virus (HCV) infection demonstrate liver enzyme elevation (LEE) after achieving sustained virologic response (SVR). Risk factors for LEE are not well characterised. We conducted a single‐centre retrospective cohort study of adults with HCV infection in the Duke University Health System who received direct‐acting antiviral therapy and achieved SVR. We performed multivariable logistic regression to assess the relationship between potential risk factors and LEE. We used generalised linear mixed‐effects models to explore longitudinal relationships between HIV and LEE. Among 1356 patients, 556 (41.0%) had LEE after achieving SVR. Higher pretreatment alanine aminotransferase (ALT) (adjusted odds ratio [aOR] 1.08 per 10 IU/L increase; 95% confidence interval [CI] 1.05–1.11) and pretreatment cirrhosis (aOR 2.26, 95% CI 1.60–3.21) were associated with higher odds of LEE; male sex was associated with lower odds of LEE (aOR 0.28, 95% CI 0.21–0.38). There was insufficient evidence of an association between HIV and LEE (aOR 0.83, 95% CI 0.47–1.44). Pretreatment ALT, cirrhosis and female sex predicted LEE in this cohort of patients with HCV infection who achieved SVR. These findings can help to identify patients at greatest risk of post‐SVR liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sustained Virologic ResponseHepatitis C, ChronicAntiviral AgentsAlanine TransaminaseHumansMaleFemaleMiddle AgedRetrospective StudiesRisk FactorsAdultPrevalenceLiverHIV InfectionsAgedLiver CirrhosisHepacivirus

Stichwörter der Autor:innen

hepatitis C eliminationhepatitis C virusliver transaminases

Substanzen

Antiviral AgentsAlanine Transaminase

Autor:innen und Institutionen

  • Department of Medicine, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
  • Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Duke Clinical Research Institute, Durham, North Carolina, USA.

ORCID-Profile: E Wilbur Woodhouse

Förderung

  • NIH-NCATS UL1TR002553
  • NIH-NIAID T32-AI055435
  • NIH-NIAID R25AI140495
  • NIH 5P30 AI064518

Zitieren

APA

Zhang, H. L., Nemeth, H., Woodhouse, E. W., Davenport, C. A., Chan, C., Okeke, N. L., & Naggie, S. (2024). Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.14009

Vancouver

Zhang HL, Nemeth H, Woodhouse EW, Davenport CA, Chan C, Okeke NL, et al. Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure. Journal of Viral Hepatitis. 2024. doi:10.1111/jvh.14009

BibTeX
@article{Zhang2024,
  author = {Zhang, Helen L and Nemeth, Hayley and Woodhouse, E Wilbur and Davenport, Clemontina A and Chan, Cliburn and Okeke, Nwora Lance and Naggie, Susanna},
  title = {Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure},
  journal = {Journal of Viral Hepatitis},
  year = {2024},
  doi = {10.1111/jvh.14009}
}
Kostenlos starten →